Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Scherrmann

Showing results (1-10 of 181) with videos related to

Pageof 19
Sort By:
The AAPS Journal|June 14, 2020
Intracellular ABCB1 as a Possible Mechanism to Explain the Synergistic Effect of Hydroxychloroquine-Azithromycin Combination in COVID-19 TherapyJ M Scherrmann
Bulletin De L'Academie Nationale De Medecine|September 16, 2000
[Biodynamics of the antigen-antibody reaction in vivo]J M Scherrmann
Annales Pharmaceutiques Francaises|January 7, 2003
[Exchanges through the blood-brain barrier]J M Scherrmann
Journal of Toxicology. Clinical Toxicology|January 1, 1994
Antibody treatment of toxin poisoning--recent advancesJ M Scherrmann
Vascular Pharmacology|January 18, 2003
Drug delivery to brain via the blood-brain barrierJ M Scherrmann
Therapie|January 1, 1994
[Immunotherapy of drug poisoning]A Sabouraud, J M Scherrmann
Clinical Chemistry|February 1, 1984
Effect of deproteinization on determination of serum digoxin by fluorescence polarization immunoassayJ M Scherrmann, R Bourdon
Therapie|May 1, 1986
[Optimal conditions of the biological study of cardiotonic glycosides]J M Scherrmann, P Sandouk
European Journal of Toxicology and Environmental Hygiene. Journal Europeen De Toxicologie|May 1, 1976
[Analysis of digoxin by a radio-immunologic]J M Scherrmann, R Bourdon
Clinical Chemistry|April 1, 1980
Cross reactivity of digitoxin in radioimmunoassay and enzyme-linked immunoassay for digoxin in plasmaJ M Scherrmann, R Bourdon
Pageof 19

Showing results (1-10 of 181) with videos related to

Sort By:
Pageof 19
The AAPS Journal|June 14, 2020
Intracellular ABCB1 as a Possible Mechanism to Explain the Synergistic Effect of Hydroxychloroquine-Azithromycin Combination in COVID-19 TherapyJ M Scherrmann
Bulletin De L'Academie Nationale De Medecine|September 16, 2000
[Biodynamics of the antigen-antibody reaction in vivo]J M Scherrmann
Annales Pharmaceutiques Francaises|January 7, 2003
[Exchanges through the blood-brain barrier]J M Scherrmann
Journal of Toxicology. Clinical Toxicology|January 1, 1994
Antibody treatment of toxin poisoning--recent advancesJ M Scherrmann
Vascular Pharmacology|January 18, 2003
Drug delivery to brain via the blood-brain barrierJ M Scherrmann
Therapie|January 1, 1994
[Immunotherapy of drug poisoning]A Sabouraud, J M Scherrmann
Clinical Chemistry|February 1, 1984
Effect of deproteinization on determination of serum digoxin by fluorescence polarization immunoassayJ M Scherrmann, R Bourdon
Therapie|May 1, 1986
[Optimal conditions of the biological study of cardiotonic glycosides]J M Scherrmann, P Sandouk
European Journal of Toxicology and Environmental Hygiene. Journal Europeen De Toxicologie|May 1, 1976
[Analysis of digoxin by a radio-immunologic]J M Scherrmann, R Bourdon
Clinical Chemistry|April 1, 1980
Cross reactivity of digitoxin in radioimmunoassay and enzyme-linked immunoassay for digoxin in plasmaJ M Scherrmann, R Bourdon
Pageof 19